Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A4.8/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Adds significant detail beyond readOnlyHint annotations: explains data sources (SEC EDGAR/XBRL for companies, FAERS for drugs), handling of off-calendar fiscal years, sorted results by primary metric, and citation URIs.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is a single paragraph that could be more structured (e.g., bullet points), but it is not overly verbose and effectively front-loads common queries.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Covers essential aspects: what it does, inputs, data sources, sorting, citations, and efficiency. Lacks explicit output format but is adequate given the tool's nature.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Despite 100% schema coverage, the description enriches parameters by explaining what each 'type' pulls (financials for company, adverse events for drug) and how 'values' should be formatted (tickers/names).

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool performs side-by-side comparisons of 2–5 companies or drugs in a single call, explicitly distinguishing it from sequential lookups and sibling tools like entity_profile.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Provides explicit guidance: 'ALWAYS PREFER over sequential single-pack lookups when comparing entities' and notes it replaces 8–15 lookups, clearly indicating when to use.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4.4/5.0
Disambiguation5/5

Each tool has a clearly distinct purpose described in detail. Even tools like ask_pipeworx, ask_pipeworx_grounded, and deep_research are differentiated by hallucination resistance, account requirements, and use cases. Polymarket tools are each specialized (arbitrage, edges, fill risk, etc.). No two tools appear to do the same thing.

Naming Consistency5/5

All tool names follow snake_case consistently. They use descriptive verb-noun patterns (e.g., ask_pipeworx, bet_research, compare_entities, subscribe). No mixing of conventions or ambiguous names.

Tool Count4/5

32 tools is on the higher side but justified by the server's broad scope covering company research, prediction markets, data lookups, memory, subscriptions, and more. Each tool serves a distinct function, though the count might feel slightly heavy for a single server.

Completeness4/5

The toolset covers core workflows for company analysis, prediction market operations, data retrieval, and system management (memory, subscriptions). Minor gaps exist (e.g., no direct tool for non-company entity profiles beyond drugs), but the overall surface is comprehensive for the intended multi-purpose assistant.